Reviewing Clinical Outcomes of Patients with the E157Q Mutation in Detroit
Sign Up to like & getrecommendations! Published in 2017 at "Open Forum Infectious Diseases"
DOI: 10.1093/ofid/ofx163.1070
Abstract: Abstract Background Integrase Strand Transfer Inhibitor (INSTIs) transmitted resistance has remained uncommon, estimated at 0.04%, with E157Q being the mutation most commonly identified. E157Q is thought to cause low-level resistance to raltegravir and elvitegravir but… read more here.
Keywords: patients e157q; e157q mutation; clinical outcomes; treatment ... See more keywords